Introduction
Wound healing is a physiological process that involves a programmed series of several biological events that include inflammation, proliferation, and remodeling (Lee et al., 2012; Greaves et al., 2013) and is coordinated by growth factors released from various cells (Takehara, 2000; Coskun et al., 2009; Kalay and Cevher, 2012) . Plateletderived growth factor (PDGF) and vascular endothelial growth factor (VEGF) are two of the most crucially involved growth factors in wound healing as they are essential for proper healing.
PDGF is one of the numerous growth factors that stimulate multiple cellular processes, including cell proliferation, chemotaxis, survival, and differentiation (Heldin, 2012) . Various cell types, including platelets, fibroblasts, and macrophages, release PDGF (Barrientos et al., 2008) . Recent studies have reported that PDGF plays a vital role in healing (Kaltalioglu and Coskun-Cevher, 2015) in various wound models; it accelerated healing (Breitbart et al., 2003; Steed, 2006) , ameliorated inflammation (Pierce et al., 1992) , and enhanced cell proliferation (Li et al., 2008) . VEGF is another proangiogenic glycoprotein that binds membrane receptors and stimulates vascular endothelial cells by acting as both a chemoattractant and mitogen (Przybylski, 2009; Lauro et al., 2014) . Many cell types, including macrophages, platelets, and keratinocytes, can produce VEGF (Duffy et al., 2004) . Several scientists have determined that VEGF is involved in angiogenesis and contributes to wound healing (Kirchner et al., 2003; Li et al., 2005; Przybylski, 2009) .
Chitosan is a polysaccharide that is obtained from the hard outer skeleton of shellfish; it consists of N-acetylglucosamine and D-glucosamine (Chen et al., 2009) . Various studies have suggested that chitosan is biodegradable and biocompatible and contributes to wound healing (Ishihara et al., 2002; Alemdaroglu et al., 2006) .
Wound healing proceeds in overlapping stages that need to be carefully and rigorously regulated to ensure proper healing; this is crucial because healing can be affected by various factors, including oxidative stress. Reactive oxygen species (ROS) can damage cells by modifying lipids, proteins, and DNA. As a result, the incurred cellular damage (referred to as oxidative stress) may contribute to the pathogenesis of various diseases (Lobo et al., 2010) . As in other metabolic processes, oxidative events occur during wound healing too. However, these events are neither entirely beneficial nor entirely detrimental for wound healing. Studies suggest that low ROS [e.g., (O 2 − ) and hydrogen peroxide (H 2 O 2 )] levels serve as second messengers in the healing process (Sundaresan et al., 1995; Guo and Dipietro, 2010) . ROS also play a role in eliminating bacterial contamination during wound healing (Sen, 2003; Rodriguez et al., 2008) . However, high ROS levels may induce cellular damage, thereby impairing wound healing (Rodriguez et al., 2008; Guo and Dipietro, 2010) .
Considering the studies in the literature, we think that dual growth factor administration might be more effective than single factor administration on oxidative events (Coskun et al., 2009; Kalay and Cevher, 2012; Kaltalioglu et al., 2013) . Therefore, the purpose of the present study was to simultaneously administer PDGF and VEGF during acute stage wound healing and evaluate resultant time-dependent effects on oxidative events in rats.
Materials and methods

Animals
The Local Animal Ethics Committee (Gazi University) approved the protocol of this study (Ref no: G.Ü.ET-11.010). Thirty-six female Wistar albino rats (healthy, adult, 200-250 g) were utilized. The rats were housed one per cage and given standard rat food and water ad libitum under standard conditions (room temperature, 12-h light/dark cycle). The rats were allocated randomly to one of three experimental groups (Figure) . 2.2. Preparation of the chitosan gels PDGF (P-4056), VEGF (V-3638), and chitosan (C-3646) were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Lactic acid (1 g) was added to 50 mL of water. Chitosan (3 g) was added and stirred. After the swelling, the remaining quantity of water (final volume: 100 mL) was added. The prepared gel was stored one night prior to application to trap air bubbles (blank chitosan gel). Then a sufficient quantity of PDGF (417 ng) and of VEGF (417 ng) were combined to prepare a solution; the concentration finally used was 7 + 7 ng/mL (PDGF + VEGF chitosan gel). The gels were stored in a refrigerator at 4-8 °C during the experiment.
Surgical procedure
The rats were anesthetized with an intramuscular injection of 50 mg/kg of ketamine HCl and 5 mg/kg xylazine HCl (Alfamine and Alfazyne, Alfasan, Woerden, Holland). The dorsum was shaved and cleaned with iodine tincture. Two equal-sized ( to be sufficient to analyze all parameters needed), excisional full-thickness skin wounds were carefully created with a surgical blade on both sides of the spine in all animals (wound length = 40 mm, breadth = 2 mm). All wounds were created by the same person and were closed with an interrupted technique at 1-cm intervals with 4/0 silk sutures (Mersilk, Ethicon, Edinburgh, Scotland).
Treatment
Following the surgery, 0.3 mL of chitosan gel containing PDGF + VEGF was topically applied to each wound once daily, using a needleless syringe. Only rats in the PDGF + VEGF chitosan gel group received this treatment. Treatment was first applied immediately after surgery. Rats in the blank chitosan gel group were treated as per the same regimen; they received the same amount of chitosan gel but without PDGF + VEGF. No treatment was performed in the control group. Figure. Experimental groups.
Six rats from each group were sacrificed with intracardiac blood aspiration under anesthesia on days 3 and 7 after wounding; these days were chosen because this is when PDGF (Cheng et al., 2007; Li et al., 2008; Kaltalioglu et al., 2013) and VEGF (Kirchner et al., 2003; Przybylski, 2009 ) have been shown to be most effective, respectively. Wound samples were collected with a surgical blade and divided into equal six parts. Collected samples were named corresponding to their positions (L1, L2, L3 and R1, R2, R3), directly placed in liquid nitrogen, and stored at −30 °C. Each of the parts was used to analyze different parameters.
Determination of NOx levels
Reactive nitrogen oxide species (NOx) levels were determined using the Griess reaction. Briefly, samples were homogenized in phosphate buffer (pH 7), centrifuged at 3500 rpm, and treated with 0.3 M sodium hydroxide (NaOH). Following incubation, vanadium trichloride (VCl 3 ) was added and the mixture was incubated for an additional 30 min at 37 °C. The mixture was then mixed with the Griess reagents, which contain N-(1-naphthyl)ethylenediamide dihydrochloride (NEDD) and sulfanilamide. The absorbance was recorded at 540 nm (UV Mini 1240, Shimadzu, Tokyo, Japan) (Miranda et al., 2001) . Sodium nitrite was used as a standard for this assay. Sample absorbance readings were run against the blank.
Determination of TBARs levels
Briefly, 1 mL of sample that had been homogenized in 0.15 M potassium chloride (KCl) was extracted with 15% trichloroacetic acid. Following centrifugation at 2000 × g, the supernatant was added to 1% butylated hydroxytoluene and 0.67% thiobarbituric acid and heated at 100 °C. The absorbance was recorded at 535 nm (UV Mini 1240, Shimadzu, Tokyo, Japan) (Casini et al., 1986) . Tetraethoxypropane solution was used as a standard for this assay. Sample absorbance readings were run against the blank.
Determination of GSH levels
A modified version of the Ellman method was used to determine glutathione (GSH) levels as per the procedure outlined by Aykac et al. (1985) . In brief, a sodium chloride/ethylenediaminetetraacetic acid/metaphosphoric acid mixture was mixed with the homogenized sample (homogenized as described in 2.6) for deproteinization. Following centrifugation, 0.5 mL of the supernatant was added to 0.2 mL of dithiobisnitrobenzoate solution and 2 mL of 0.3 M disodium hydrogen phosphate. The GSH level in the tissue sample was determined from its absorbance at 412 nm (UV Mini 1240, Shimadzu, Tokyo, Japan). Sample absorbance readings were run against the blank. 2.8. Determination of AA levels Ascorbic acid (AA) levels were estimated as previously described (Berger et al., 1989) . In brief, homogenized (on ice in 0.35 M perchloric acid) samples were centrifuged for 3 min at 15,000 × g. A 400-μL aliquot of either the standard (AA) or sample was mixed with 100 μL of color reagent in a centrifugal analyzer tube. Following incubation, 600 μL of 65% (v/v) H 2 SO 4 was added. The absorbance was determined at 520 nm (UV Mini 1240, Shimadzu, Tokyo, Japan). Sample absorbance readings were run against the blank.
Determination of SOD activity
Superoxide dismutase (SOD) activity was detected using the method previously described by Sun et al. (1988) . The homogenized (in ice-cold 0.9% NaCl) sample was centrifuged at 7000 rpm, and an ethanol/chloroform mixture (3:5, v/v) was added to the supernatant. After a second round of centrifugation, the assay reagent [150 µM nitroblue tetrazolium (NBT), 0.6 mM ethylenediaminetetraacetic acid (EDTA), 3 mM xanthine, 400 mM Na 2 CO 3 , and 1 g/L bovine serum albumin (BSA)] was mixed with the supernatant. Xanthine oxidase was added to this mixture. Following incubation, copper chloride (CuCl 2 ) was added to the mixture. SOD activity was recorded using the absorbance at 560 nm (UV Mini 1240, Shimadzu, Tokyo, Japan). 1 U is defined as the quantity of enzyme causing 50% inhibition of NBT. Sample absorbance readings were run against the blank.
Statistical analysis
The results are presented as the mean ± standard deviation (SD). Groupwise differences were calculated using oneway ANOVA. Differences with P < 0.001 were considered statistically significant. Tables 1 and 2 .
Results
Measurement results are summarized in
NOx levels
Blank chitosan gel administration (blank chitosan gel group) significantly increased NOx levels in wound tissue on days 3 and 7 as compared to the control group (P < 0.001). Comparing the results of the PDGF + VEGF chitosan gel group with those of the other groups showed that the dual growth factor administration significantly increased NOx levels on day 3 (P < 0.001). Moreover, in the PDGF + VEGF chitosan gel group, NOx level was also significantly decreased on day 7 as compared to the blank chitosan gel group (P < 0.001).
TBARs levels
Rats in the PDGF + VEGF chitosan gel group had significantly lower TBARs levels than those in the blank chitosan gel group on day 7 (P < 0.001). However, there was no significant (P > 0.001) alteration in the PDGF + VEGF chitosan gel group when compared with the other groups on day 3 (Table 1) .
GSH levels
In the PDGF + VEGF chitosan gel group, GSH levels were also significantly increased on day 3 as compared to the other groups (P < 0.001) ( Table 2) . 3.4. AA levels No significant difference in AA level was observed in any of the three groups (P > 0.001) ( Table 2) .
SOD activities
No significant difference in SOD activity was observed in any of the three groups (P > 0.001) ( Table 2 ).
Discussion
The current study demonstrated that PDGF + VEGF administration affects NOx, TBARs, and GSH levels in wound healing. Additionally, these data suggest that this effect may be time-dependent. Based the data reported here and our previous study, we may infer that dual growth factor administration is more effective than single factor administration on oxidative markers (decreasing TBARs and increasing GSH levels) during wound healing (Kaltalioglu et al., 2013) .
Chitosan, used as a vehicle for growth factor administration in our study, showed a statistically significant effect by increasing NOx levels compared to the control group (untreated) (P < 0.001), but it did not show a significant effect on other oxidative markers (TBARs, GSH, AA, and SOD) (P > 0.001). Previous studies have indicated that chitin and its derivatives (such as chitosan) may have different effects (increasing or decreasing) on NO, depending on dosage, source, and preparation methods (Hwang et al., 2000; Yu et al., 2004; Pattani et al., 2009) .
NO is a highly reactive biological messenger (Hou et al., 1999; Esplugues, 2002) . Various cell types, including macrophages, platelets, endothelial cells, and fibroblasts are capable of producing NO in wounded tissue through the action of three different nitric oxide synthase isotypes: inducible (iNOS), neuronal (nNOS), and endothelial (eNOS) (Frank et al., 2002; Schwentker et al., 2002) . Comparing the results of the PDGF + VEGF chitosan gel group with those of the other groups showed that the dual growth factor administration significantly increased NOx levels on day 3 (P < 0.001). VEGF mediates the chemotaxis of macrophages (Shen et al., 1993; Barleon et al., 1996; Sawano et al., 2001 ) and stimulates vascular endothelial cells by acting as both a chemoattractant and mitogen 7-day (n = 6) 411.26 ± 81.42a 27.17 ± 4.41a Table 2 . Antioxidant markers on two different intervals in wound tissue. All data are expressed as mean ± standard deviation. * P < 0.001 as compared with the control group. a P < 0.001 as compared with the blank chitosan gel group.
Control group (n = 12) 3-day (n = 6) 2.23 ± 0.49 0.14 ± 0.02 282.43 ± 12.44
7-day (n = 6) 3.62 ± 0.73 0.10 ± 0.01 310.65 ± 11.18
Blank chitosan gel group (n = 12) 3-day (n = 6) 2.41 ± 0.71 0.10 ± 0.01 271.71 ± 8.78
7-day (n = 6) 2.85 ± 0.64 0.23 ± 0.11 309.42 ± 10.49 PDGF + VEGF chitosan gel group (n = 12) 3-day (n = 6) 10.42 ± 2.78*,a 0.15 ± 0.12 280.98 ± 5.63
7-day (n = 6) 5.14 ± 1.89 0.16 ± 0.08 308.48 ± 12.84 (Przybylski, 2009) . It is has been reported that VEGF stimulates eNOS and iNOS expression and NO production in endothelial cells (Kroll and Papapetropoulos et al., 1997; Waltenberger, 1998; Park et al., 2002; Koai et al., 2010) . In contrast, numerous studies have suggested that PDGF administration suppresses NO production (ScottBurden et al., 1992; Hishikawa et al., 1996; Kunz et al., 1997; Kaltalioglu et al., 2013) . Additionally, in the PDGF + VEGF chitosan gel group, NOx level was also significantly decreased on day 7 as compared to the blank chitosan gel group (P < 0.001). This determined difference between days 3 and 7, which is caused by the administration of PDGF + VEGF, may have occurred due to time-dependent changes in cellular status during the healing process; various cell types (e.g., macrophages and endothelial cells) are involved in wound healing and become dominant at different stages in the process. Lipid peroxidation can be monitored using TBARs levels. There were no significant differences in TBARs levels between the PDGF + VEGF chitosan gel group and the other groups on day 3. However, tissue TBARs levels were significantly lower in the PDGF + VEGF chitosan gel group than in the blank chitosan gel group on day 7 (P < 0.001). This decrease on day 7 is similar to that found in our previous study (Kaltalioglu et al., 2013) . PDGF + VEGF chitosan gel administration may have an antioxidative effect compared to the blank chitosan gel group on day 7. Additionally, this decrease parallels the simultaneous NOx decrease.
GSH is an important antioxidant tripeptide that protects the cells against oxidative stress (Lushchak, 2012) . GSH levels were elevated on day 3 in the PDGF + VEGF group as compared to the other groups (P < 0.001). This result is supported by findings from our previous studies (Kaltalioglu et al., 2013) . Similarly, Iantomasi et al. (1999) determined that in serum-starved NIH3T3 cells cellular GSH content was increased by PDGF-BB stimulation. The existing literature suggests that both PDGF and VEGF administration increase GSH levels. For instance, Kuzuya et al. (2001) showed that VEGF administration significantly increased GSH levels in bovine aortic endothelial cells. A possible explanation for the increase observed in our study might be that growth factors [like PDGF-BB (Chen et al., 1997) ] may trigger signal transduction pathways, thereby causing phospholipase A2 (PLA2) activation and prostaglandin E2 (PGE2) release; GSH plays an essential role in this process (Harvey and Ferrier, 2010; Kaltalioglu et al., 2013) . In considering this result, it can be an important indication that dual growth factor administration increases the GSH level in wound tissue during the healing process, especially on day 3.
AA levels and SOD activities were not significantly altered in the PDGF + VEGF chitosan gel group as compared to the other groups (P > 0.001). While TBARs levels decrease, AA levels and SOD activity do not change. This suggests that alternative antioxidant defense mechanisms (such as GSH, catalase, and vitamin E) are used to scavenge increased ROS.
In conclusion, PDGF + VEGF administration affects oxidative events in wound tissue by altering NOx, decreasing TBARs, and increasing GSH levels. These results may help elucidate the effect of dual growth factor administration on oxidant markers during acute stage wound healing. The present study also provides valuable insights for the development of therapeutic targets that promote wound healing.
